These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26663568)

  • 1. Editorial Comment to Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
    Urakami S; Okaneya T
    Int J Urol; 2016 Feb; 23(2):158-9. PubMed ID: 26663568
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
    Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y
    Int J Urol; 2016 Feb; 23(2):153-8. PubMed ID: 26607995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Xylinas E; Necchi A;
    Eur Urol; 2017 Sep; 72(3):473-474. PubMed ID: 28502719
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Association Between Lymph Node Yield and Survival Among Patients Undergoing Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Tract.
    Petros FG; Matin SF
    Eur Urol; 2018 May; 73(5):811-812. PubMed ID: 29249290
    [No Abstract]   [Full Text] [Related]  

  • 5. Urothelial carcinoma of the upper urinary tracts: current knowledge and future perspectives.
    Margulis V; Hutchinson R; Krabbe LM
    Minerva Urol Nefrol; 2016 Aug; 68(4):348-9. PubMed ID: 27404376
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial Comment to Risk stratification using Bmi-1 and Snail expression is a useful prognostic tool for patients with upper tract urothelial carcinoma.
    Matsumoto R
    Int J Urol; 2016 Dec; 23(12):1037. PubMed ID: 27804196
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial Comment on: Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes by Metcalfe et al.
    Somani BK
    J Endourol; 2017 Sep; 31(9):954-955. PubMed ID: 28762779
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comment from Dr Shiota to Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study.
    Shiota M
    Int J Urol; 2021 Dec; 28(12):1253. PubMed ID: 34545645
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Effectiveness of Adjuvant Chemotherapy after Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Laguna MP
    J Urol; 2017 Oct; 198(4):739-740. PubMed ID: 28905781
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial Comment from Dr Defidio to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Defidio L
    Int J Urol; 2018 Apr; 25(4):381-382. PubMed ID: 29577441
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial Comment from Dr Castelli to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Castelli E
    Int J Urol; 2018 Apr; 25(4):380-381. PubMed ID: 29520838
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial Comment from Dr Lonati and Dr Moschini to Stage and cancer-specific mortality differ within specific Asian ethnic groups in upper tract urothelial carcinoma: North American population-based study.
    Lonati C; Moschini M
    Int J Urol; 2021 Dec; 28(12):1252-1253. PubMed ID: 34580928
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial Comment to Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Zhang Z; Zhou F
    Int J Urol; 2015 May; 22(5):467-8. PubMed ID: 25808233
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial Comment from Dr Miyata and Dr Sakai to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Miyata Y; Sakai H
    Int J Urol; 2016 Mar; 23(3):230-1. PubMed ID: 26840209
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment from Dr Sakano and Dr Matsuyama to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Sakano S; Matsuyama H
    Int J Urol; 2016 Mar; 23(3):231-2. PubMed ID: 26822627
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.